The short answer
For men with mild to moderate erectile dysfunction who have had a proper workup, the P-Shot is a reasonable option with a good safety profile and modest evidence of benefit at 12 to 24 weeks. For men seeking size, or who have not had ED evaluated, it is not worth it.
An Honest Assessment
We offer this treatment, and we would rather you decided with real information than book on the strength of marketing.
The case for it
- The pooled trial data is cautiously positive. A 2025 meta-analysis of seven randomized controlled trials covering 660 patients found significant improvement in erectile function scores at 12 and 24 weeks compared with control.
- The safety profile is genuinely good. It uses your own blood. Reported side effects across studies were mild and transient with no major adverse events.
- It does not preclude anything else. Trying it does not rule out oral medication or other approaches later.
The case against it
- The evidence is not settled. A 2024 review of four studies concluded there is still no conclusive evidence of efficacy.
- Preparation varies enormously between clinics. Reviewers repeatedly flag inconsistency in how PRP is prepared, dosed and followed up. "The P-Shot" at two clinics may be materially different products.
- Benefits are small to moderate, not transformative. Anyone promising dramatic change is overselling.
- It is not covered by insurance and is not cheap.
- Oral medication has a far stronger evidence base and works for the large majority of men with ED.
What we would tell you at consultation
If you have not tried first-line treatment and have not had a cardiovascular and hormonal workup, do those first. They are better supported, frequently more effective, and the workup occasionally finds something that matters a great deal more than your erections.
If you have done that, and you want an autologous option with a reasonable safety profile and modest expected benefit, the P-Shot is a defensible choice.
Who Gets the Most Benefit
Across the literature, men with mild to moderate dysfunction tend to respond better than men with severe disease. Where ED is driven by advanced vascular disease, poorly controlled diabetes, or significant nerve damage, expectations should be lower.
Men whose ED is largely psychological are also unlikely to be well served by an injection — that responds to a different kind of help.
What It Will Not Do
It will not increase size — see the comparison with filler. It will not overcome an ongoing medication effect; several common drug classes cause ED, and adjusting those with your prescriber is often the higher-value step. It will not fix a vascular problem that needs medical management.
Our Position
We will happily discuss it. We will also tell you if we think the workup, a medication review, or first-line treatment would serve you better — because for a meaningful proportion of men, they would.
Read what the P-Shot is for the mechanism, or how long it lasts if you are weighing the ongoing cost.
